J8705 Topotecan - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Topotecan

Brand Name:

Hycamtin

Strength:

0.25 mg

HCPCS:

J8705

SEER*Rx Category:

Chemotherapy

Major Drug Class:

Topoisomerase I Inhibitor

Minor Drug Class:

Campothecin Analogs

Oral (Y/N):

Yes

FDA Approval Year:

1996

FDA Discontinuation Year:

CMS Effective Date:

Jan. 1, 2009

CMS Discontinuation Date:

Status:

In Use